Search or
𝛼SK
𝛼SKENTITY
Oxford Biomedica PLC (OXB LN)
Oxford Biomedica PLC (OXB LN)
30
Analysis
Health Care • United Kingdom
Oxford Biomedica is a gene and cell therapy group focused on developing treatments for serious diseases based around its FDA approved lentiviral vector delivery platform. The Company leverages this platform to develop in vivo and ex vivo products in-house and with global Pharmaceutical and Biotech partners and has created it's own portfolio of gene and cell therapy product candidates.
morex